{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:06:43Z","timestamp":1790874403813,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.cca.2024.119682","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T12:56:18Z","timestamp":1713704178000},"page":"119682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Elevated serum HE4 levels as a novel biomarker of disease severity and hepatic fibrosis in autoimmune hepatitis"],"prefix":"10.1016","volume":"559","author":[{"given":"Zhi","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caina","family":"Nian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyuan","family":"Nian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cca.2024.119682_b0005","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/01.AOG.0000216004.22588.ce","article-title":"Incidence and survival rates for female malignant germ cell tumors","volume":"107","author":"Smith","year":"2006","journal-title":"Obstetrics and gynecology"},{"issue":"4","key":"10.1016\/j.cca.2024.119682_b0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/jclinpath-2012-201031","article-title":"Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review","volume":"66","author":"Ferraro","year":"2013","journal-title":"J. Clin. Pathol."},{"issue":"12","key":"10.1016\/j.cca.2024.119682_b0015","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1515\/cclm-2012-0373","article-title":"HE4 in gynecological cancers: report of a European investigators and experts meeting","volume":"50","author":"Plebani","year":"2012","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2024.119682_b0020","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.clinbiochem.2018.08.003","article-title":"Serum human epididymis protein 4 vs. carbohydrate antigen 125 in ovarian cancer follow-up","volume":"60","author":"Ferraro","year":"2018","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2024.119682_b0025","first-page":"1","article-title":"HE4 in ovarian cancer: from discovery to clinical application","volume":"55","author":"Montagnana","year":"2011","journal-title":"Adv. Clin. Chem."},{"issue":"9","key":"10.1016\/j.cca.2024.119682_b0030","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/bjc.2011.109","article-title":"Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients","volume":"104","author":"Bignotti","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cca.2024.119682_b0035","doi-asserted-by":"crossref","unstructured":"L. Li, J. Wan, G. Cai, L. Yuan, J. Liang, J. Song, F. Wang, M., Liu, Value of serum human epididymis secretory protein 4 as a marker for differential diagnosis of malignant and benign gynecological diseases of patients in southern China, Clinica Chimica Acta; International Journal of Clinical Chemistry 459 (2016) 170\u2013176.","DOI":"10.1016\/j.cca.2016.06.010"},{"key":"10.1016\/j.cca.2024.119682_b0040","doi-asserted-by":"crossref","unstructured":"B. Nagy Jr., Z.T. Krasznai, H. Balla, M. Csob\u00e1n, P. Antal-Szalm\u00e1s, Z. Hern\u00e1di, J. Kappelmayer, Elevated human epididymis protein 4 concentrations in chronic kidney disease, Ann. Clin. Biochem. 49 (Pt 4) (2012) 377\u2013380.","DOI":"10.1258\/acb.2011.011258"},{"issue":"42","key":"10.1016\/j.cca.2024.119682_b0045","doi-asserted-by":"crossref","first-page":"67748","DOI":"10.18632\/oncotarget.11682","article-title":"Elevated serum concentrations of HE4 as a novel biomarker of disease severity and renal fibrosis in kidney disease","volume":"7","author":"Wan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cca.2024.119682_b0050","doi-asserted-by":"crossref","first-page":"110701","DOI":"10.1016\/j.clinbiochem.2023.110701","article-title":"Serum human epididymis protein 4 is associated with disease severity in patients with IgA nephropathy","volume":"123","author":"Luo","year":"2023","journal-title":"Clin. Biochem."},{"issue":"2","key":"10.1016\/j.cca.2024.119682_b0055","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jchf.2012.11.005","article-title":"The WAP four-disulfide core domain protein HE4: a novel biomarker for heart failure","volume":"1","author":"de Boer","year":"2013","journal-title":"JACC. Heart Failure"},{"key":"10.1016\/j.cca.2024.119682_b0060","doi-asserted-by":"crossref","unstructured":"B. Nagy Jr., B. Nagy, L. Fila, L.A. Clarke, F. G\u00f6nczy, O. Bede, D. Nagy, R. \u00dajhelyi, \u00c1. Szab\u00f3, A. Anghelyi, M. Major, Z. Bene, Z. Fejes, P. Antal-Szalm\u00e1s, H.P. Bhattoa, G. Balla, J. Kappelmayer, M.D. Amaral, M. Macek Jr., I. Balogh, Human Epididymis Protein 4: A Novel Serum Inflammatory Biomarker in Cystic Fibrosis, Chest 150 (3) (2016) 661\u2013672.","DOI":"10.1016\/j.chest.2016.04.006"},{"issue":"11","key":"10.1016\/j.cca.2024.119682_b0065","first-page":"2167","article-title":"Human epididymis protein 4 as a new diagnostic biomarker for rheumatoid arthritis-associated interstitial lung disease","volume":"40","author":"Lin","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.cca.2024.119682_b0070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nm.2989","article-title":"Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis","volume":"19","author":"LeBleu","year":"2013","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.cca.2024.119682_b0075","doi-asserted-by":"crossref","first-page":"C789","DOI":"10.1152\/ajpcell.00230.2013","article-title":"Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis","volume":"305","author":"Mallat","year":"2013","journal-title":"American journal of physiology, Cell Physiology"},{"issue":"4","key":"10.1016\/j.cca.2024.119682_b0080","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"Autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.cca.2024.119682_b0085","doi-asserted-by":"crossref","first-page":"101772","DOI":"10.1016\/j.clinre.2021.101772","article-title":"Non-invasive diagnosis and follow-up of autoimmune hepatitis","volume":"46","author":"Lemoinne","year":"2022","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.cca.2024.119682_b0090","first-page":"100149","volume":"2","author":"Rahim","year":"2020"},{"issue":"2","key":"10.1016\/j.cca.2024.119682_b0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5009\/gnl15352","article-title":"Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions","volume":"10","author":"Czaja","year":"2016","journal-title":"Gut and Liver"},{"key":"10.1016\/j.cca.2024.119682_b0100","doi-asserted-by":"crossref","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"4","author":"Mieli-Vergani","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"9","key":"10.1016\/j.cca.2024.119682_b0105","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1177\/2050640619872408","article-title":"Clinical management of autoimmune hepatitis","volume":"7","author":"Pape","year":"2019","journal-title":"United European Gastroenterol J"},{"issue":"48","key":"10.1016\/j.cca.2024.119682_b0110","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000023428","article-title":"Clinical significance of serum human epididymis protein 4 in liver fibrosis: An experimental study","volume":"99","author":"Hou","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cca.2024.119682_b0115","first-page":"213","article-title":"Human epididymis protein 4 concentration is not associated with liver fibrosis and cirrhosis in a case control study, Clinica Chimica Acta","volume":"484","author":"Zhang","year":"2018","journal-title":"International Journal of Clinical Chemistry"},{"issue":"6","key":"10.1016\/j.cca.2024.119682_b0120","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/bjs.10095","article-title":"Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma","volume":"103","author":"Wang","year":"2016","journal-title":"Br. J. Surg."},{"issue":"2","key":"10.1016\/j.cca.2024.119682_b0125","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"17","key":"10.1016\/j.cca.2024.119682_b0130","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1038\/sj.onc.1205363","article-title":"The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms","volume":"21","author":"Bingle","year":"2002","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.cca.2024.119682_b0135","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1515\/cclm-2012-0097","article-title":"Human epididymis protein 4 (HE4) in benign and malignant diseases","volume":"50","author":"Hertlein","year":"2012","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.cca.2024.119682_b0140","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1095\/biolreprod45.2.350","article-title":"A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors","volume":"45","author":"Kirchhoff","year":"1991","journal-title":"Biol. Reprod."},{"issue":"4","key":"10.1016\/j.cca.2024.119682_b0145","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s13277-012-0356-9","article-title":"Serum HE4 as a diagnostic and prognostic marker for lung cancer","volume":"33","author":"Iwahori","year":"2012","journal-title":"Tumour Biology\u202f: the Journal of the International Society for Oncodevelopmental Biology and Medicine"},{"key":"10.1016\/j.cca.2024.119682_b0150","doi-asserted-by":"crossref","unstructured":"B. Nagy Jr., H.P. Bhattoa, Z. Steiber, M. Csob\u00e1n, M. Szilasi, G. M\u00e9hes, M. M\u00fcller, J. L\u00e1z\u00e1r, J. Kappelmayer, P. Antal-Szalm\u00e1s, Serum human epididymis protein 4 (HE4) as a tumor marker in men with lung cancer, Clin. Chem. Lab. Med. 52 (11) (2014) 1639\u20131648.","DOI":"10.1515\/cclm-2014-0041"},{"issue":"1","key":"10.1016\/j.cca.2024.119682_b0155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cardfail.2016.05.002","article-title":"HE4 Serum Levels Are Associated with Heart Failure Severity in Patients With Chronic Heart Failure","volume":"23","author":"Piek","year":"2017","journal-title":"J. Card. Fail."},{"issue":"2","key":"10.1016\/j.cca.2024.119682_b0160","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3748\/wjg.v20.i2.475","article-title":"Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"20","author":"Sumida","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.cca.2024.119682_b0165","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1136\/gut.2007.126417","article-title":"Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"56","author":"Yoneda","year":"2007","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cca.2024.119682_b0170","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.20506","article-title":"Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C","volume":"41","author":"Ziol","year":"2005","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"8","key":"10.1016\/j.cca.2024.119682_b0175","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/gutjnl-2015-309260","article-title":"The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa","volume":"65","author":"Lemoine","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.cca.2024.119682_b0180","first-page":"NA","article-title":"Pitfalls of liver stiffness measurement: A 5-year prospective study of 13,369 examinations","author":"Cast\u00e9ra","year":"2010","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"4","key":"10.1016\/j.cca.2024.119682_b0185","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/0004563217741509","article-title":"Performance of autotaxin as a serum marker for liver fibrosis","volume":"55","author":"Ikeda","year":"2018","journal-title":"Ann. Clin. Biochem."},{"issue":"6","key":"10.1016\/j.cca.2024.119682_b0190","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/jcla.21954","article-title":"Human Epididymis Protein 4: A Novel Biomarker for Lupus Nephritis and Chronic Kidney Disease in Systemic Lupus Erythematosus","volume":"30","author":"Yang","year":"2016","journal-title":"J. Clin. Lab. Anal."},{"issue":"11","key":"10.1016\/j.cca.2024.119682_b0195","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1373\/clinchem.2010.157073","article-title":"Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases","volume":"57","author":"Escudero","year":"2011","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.cca.2024.119682_b0200","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/gutjnl-2020-321790","article-title":"Guidelines on the management of ascites in cirrhosis","volume":"70","author":"Aithal","year":"2021","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.cca.2024.119682_b0205","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1521-690X(03)00052-6","article-title":"Mechanisms of water and sodium retention in cirrhosis and the pathogenesis of ascites","volume":"17","author":"C\u00e1rdenas","year":"2003","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124019235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124019235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:46:28Z","timestamp":1790873188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898124019235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":41,"alternative-id":["S0009898124019235"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2024.119682","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated serum HE4 levels as a novel biomarker of disease severity and hepatic fibrosis in autoimmune hepatitis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2024.119682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119682"}}